Anakinra
Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist (IL-1Ra). The difference between anakinra and the native human IL-1Ra is that anakinra has an extra methionine residue at the amino terminus. It is manufactured by using the E. coli expression system. Anakinra is composed of 153 amino acid residues. FDA approved on November 14, 2001.
| Trivial name | IL1RN |
| Catalog Number | TP-085CL |
| Alternative Name(s) | Anakinra |
| Research Area | Immunoregulation |
| Molecular Formula | C759H1186N208O232S10 |
| CAS# | 143090-92-0 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Anakinra-22423.htm |
| Additional Information | For the treatment of adult rheumatoid arthritis and treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). |